Saturday, November 2, 2024
HomeTagsMarinus Pharmaceuticals

Marinus Pharmaceuticals

Marinus Pharmaceuticals Receives Positive CHMP Opinion for ZTALMY for the Adjunctive Treatment of Seizures Associated With CDKL5 Deficiency Disorder

Marinus Pharmaceuticals, Inc, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that the Committee for Medicinal Products...

Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome

Marinus Pharmaceuticals, Inc, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that the U.S. Food and Drug...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics